Emerald Health Therapeutics Announces New At-the-Market Equity Program

 – August 13, 2020) – Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the “Company”) today announced that it has established an at-the-market equity program (“ATM Program”) that allows the Company to issue common shares from treasury (“Common Shares”) having an aggregate gross sales price of up to $3.25 million to the public from time toContinue reading “Emerald Health Therapeutics Announces New At-the-Market Equity Program”

HEXO Corp. Announces C$34,500,000 At-the-Market Offering Program

— HEXO Corp. (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced that it has established an at-the-market equity program (the “ATM Program”) that allows the Company to issue up to C$34,500,000 (or its U.S. dollar equivalent) of common shares (the “Common Shares”) from treasury to the public from time to time, at theContinue reading “HEXO Corp. Announces C$34,500,000 At-the-Market Offering Program”